IntrinsicIntrinsic
← Scroll for more →

Financial Statements — CLLS

Balance Sheet

(in millions USD)
MetricQ4 2025Q2 2025Q4 2024Q2 2024Q4 2023Q2 2023Q4 2022Q2 2022Q4 2021Q2 2021
Cash & Equivalents61.5359.81143.25149.04136.7184.3989.79129.44185.64248.23
Inventory------------0.00----2.47
Total Current Assets------------122.04175.17225.43280.35
Total Non-current Assets88.48123.3396.48101.34101.27114.39117.41145.72156.65177.21
Total Assets324.72353.97383.54407.15334.27227.67261.22320.88382.08457.57
Total Current Liabilities145.75167.43166.27159.63155.1442.0548.1355.2849.3551.45
Total Non-current Liabilities103.0789.4286.2498.9094.4389.0772.2885.0896.25103.80
Total Liabilities*248.82256.86252.51258.54249.58131.12135.28140.36145.60155.24
Retained Earnings------------------(586.28)
Total Stockholder Equity75.9097.11131.03148.6184.7096.56125.94180.52236.47302.32
← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2025Q2 2024Q2 2023Q2 2022Q2 2021
Total Revenue16.738.060.181.3511.18
Research & Development23.0823.5222.1429.0531.15
Selling, General & Admin5.083.883.958.419.34
Total Operating Expenses--26.7125.6636.8452.10
Operating Income(9.59)(17.21)(23.66)(34.08)(37.48)
Pretax Income--(25.50)------
Tax Provision0.00(0.19)(0.26)0.000.00
Net Income(23.74)(25.27)(13.58)(19.45)(41.61)
Basic EPS(0.24)(0.28)(0.19)(0.42)(0.88)
Diluted EPS(0.24)(0.28)(0.19)(0.42)(0.88)
← Scroll for more columns →

Cash Flow Statement

(in millions USD)
MetricQ2 2025Q2 2024Q2 2023Q2 2022Q2 2021
Operating Cash Flow(27.47)28.87(47.37)(60.18)(53.05)
Investing Cash Flow(48.49)(108.48)(1.56)(2.54)9.94
Financing Cash Flow(8.36)90.4139.6010.3152.63
← Scroll for more columns →